Clinical AI company Sensyne Health has signed a production contract with the UK’s Department of Health & Social Care (DHSC) to use its AI diagnostic lateral flow test reader, MagnifEye, as part of the government’s asymptomatic testing programme. The contract is part of a phased national roll-out of testing over a three-month period in care…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 to use its AI diagnostic lateral flow test reader, MagnifEye, as part of the government's asymptomatic testing programme. ){kind=link}